Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| macrophage | 10 studies | 33% ± 14% | |
| type I pneumocyte | 8 studies | 30% ± 13% | |
| microglial cell | 7 studies | 27% ± 8% | |
| astrocyte | 7 studies | 34% ± 15% | |
| oligodendrocyte | 7 studies | 27% ± 10% | |
| endothelial cell | 6 studies | 24% ± 7% | |
| epithelial cell | 5 studies | 27% ± 7% | |
| type II pneumocyte | 5 studies | 20% ± 6% | |
| GABAergic neuron | 5 studies | 41% ± 19% | |
| myeloid cell | 4 studies | 29% ± 11% | |
| glutamatergic neuron | 4 studies | 52% ± 21% | |
| oligodendrocyte precursor cell | 4 studies | 26% ± 8% | |
| fibroblast | 4 studies | 19% ± 2% | |
| interneuron | 4 studies | 38% ± 20% | |
| mesothelial cell | 3 studies | 22% ± 3% | |
| alveolar macrophage | 3 studies | 32% ± 9% | |
| monocyte | 3 studies | 23% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 100% | 1035.66 | 89 / 89 | 100% | 17.93 | 900 / 901 |
| brain | 100% | 990.01 | 2641 / 2642 | 100% | 18.26 | 704 / 705 |
| ovary | 100% | 477.53 | 180 / 180 | 100% | 12.63 | 428 / 430 |
| lung | 100% | 1128.35 | 577 / 578 | 100% | 13.62 | 1150 / 1155 |
| uterus | 100% | 498.93 | 170 / 170 | 99% | 14.02 | 456 / 459 |
| thymus | 100% | 935.33 | 653 / 653 | 99% | 21.60 | 598 / 605 |
| breast | 100% | 555.59 | 459 / 459 | 98% | 16.81 | 1101 / 1118 |
| adrenal gland | 100% | 552.88 | 258 / 258 | 98% | 12.97 | 225 / 230 |
| esophagus | 100% | 1044.31 | 1445 / 1445 | 98% | 10.92 | 179 / 183 |
| liver | 100% | 465.80 | 226 / 226 | 98% | 9.14 | 396 / 406 |
| pancreas | 99% | 407.88 | 324 / 328 | 98% | 11.87 | 175 / 178 |
| prostate | 100% | 536.38 | 245 / 245 | 92% | 6.36 | 463 / 502 |
| skin | 100% | 975.27 | 1808 / 1809 | 90% | 12.04 | 423 / 472 |
| bladder | 100% | 567.24 | 21 / 21 | 88% | 9.16 | 446 / 504 |
| stomach | 100% | 644.98 | 359 / 359 | 86% | 6.52 | 246 / 286 |
| intestine | 100% | 585.10 | 966 / 966 | 78% | 5.98 | 412 / 527 |
| spleen | 100% | 478.42 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 14.39 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.14 | 1 / 1 |
| adipose | 100% | 578.31 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 681.51 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 434.27 | 794 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 5.75 | 28 / 29 |
| heart | 96% | 439.87 | 824 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 95% | 8.31 | 76 / 80 |
| peripheral blood | 21% | 68.96 | 199 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0015031 | Biological process | protein transport |
| GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
| GO_0070273 | Molecular function | phosphatidylinositol-4-phosphate binding |
| GO_1901981 | Molecular function | phosphatidylinositol phosphate binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0010314 | Molecular function | phosphatidylinositol-5-phosphate binding |
| GO_0032266 | Molecular function | phosphatidylinositol-3-phosphate binding |
| Gene name | SNX24 |
| Protein name | Sorting nexin 24 Sorting nexin-24 |
| Synonyms | UNQ654/PRO1284 SBBI31 |
| Description | FUNCTION: May be involved in several stages of intracellular trafficking. . |
| Accessions | ENST00000513881.5 [Q9Y343-2] ENST00000511545.5 H0Y8V0 H0YA25 A8MXB7 ENST00000503149.5 Q9Y343 ENST00000395451.8 ENST00000261369.9 [Q9Y343-1] ENST00000506996.5 [Q9Y343-2] |